TAG:
laboratory companies
UnitedHealth Sues 5 Tox Labs, Says It Was Defrauded of $50M
By Joseph Burns | From the Volume XXIII No. 7 – May 23, 2016 Issue
FLORIDA IS ONCE AGAIN GROUND ZERO for a major case of lab testing fraud. UnitedHealthcare has filed suit against five toxicology laboratory companies, three general partners in those companies, eight urinalysis referral sources, and other entities, claiming the defendants defrauded t…
A Pantheon of Greatest Lab Physician-Businessmen
By R. Lewis Dark | From the Volume XXIII No. 4 – March 21, 2016 Issue
WHEN IT COMES TO THE CLINICAL LABORATORY BUSINESS, generally included in the lab industry’s Pantheon of Greatest Physician (Pathologist) Businessmen are Paul A. Brown, MD, and James B. Powell, MD. I’d like to nominate another physician to this list: Marc D. Grodman, MD. During the 1970s and 1980…
UnitedHealthcare Comments on Labs’ Use of “Fee Waivers”
By Joseph Burns | From the Volume XXII, Number 17 – December 7, 2015 Issue
PATHOLOGISTS AND LAB SCIENTISTS are familiar with the well-known scientific principle that, “for every action, there is a reaction.†This principle also holds true for the managed care contracting practices of the two national laboratory companies. One action that is the subject of this story is…
WSJ ‘Sticks’ Theranos, Raises Serious Questions
By Robert Michel | From the Volume XXII No. 15 – October 26, 2015 Issue
CEO SUMMARY: Following months of investigation, reporter John Carreyrou of The Wall Street Journal published back-to-back reports about aspects of Theranos that the…
October 5, 2015 Intelligence: Late Breaking Lab News
By Robert Michel | From the Volume XXII No. 14 – October 5, 2015 Issue
More venture capital money is moving into the medical laboratory industry in India. In September, Metropolis Healthcare Ltd of Mumbai, India, disclosed that Carlyle, a private equity company, had purchased a 36.5% ownership interest in the lab company. In April, Warburg Pincus …
Is New Cycle of Fraud Plaguing Lab Industry?
By Robert Michel | From the Volume XXII No. 12 – August 24, 2015 Issue
CEO SUMMARY: Taken collectively, the growing number of federal investigations of clinical lab companies and health insurer lawsuits against lab companies alleging fraudulent business practices signals a disturbing new trend for the lab industry. Although these allegations are lev…
Cigna Audits Tox Test Labs For Proof that Patients Paid
By Joseph Burns | From the Volume XXII No. 12 – August 24, 2015 Issue
CEO SUMMARY: In an unusually strong move, health insurer Cigna is auditing laboratories, including some labs that do toxicology testing. In these audits, the health insurer seeks documentation that the testing is medically necessary and that the laboratories are collecting copaym…
Opko Pays $1.47 Billion to Buy Bio-Reference Lab
By Robert Michel | From the Volume XXII NO. 9 – June 22, 2015 Issue
CEO SUMMARY: It’s a case of the little fish gobbling the big fish, as Opko Health – with revenue of $91 million – will be acquiring Bio-Reference Laboratories, with revenue of $832 million. But the more interesting aspect of the story is that the CEO of Opko Health is a physi…
OIG Says It Is Ready to Target Physicians in Kickback Cases
By Robert Michel | From the Volume XXII NO. 9 – June 22, 2015 Issue
PHYSICIANS WHO PARTICIPATE IN schemes that violate anti-kickback and fraud statutes will be at greater risk of prosecution by federal healthcare officials. This development comes following the June 9 release by the OIG of “Fraud Alert: Physician Compensation Arrangements May Result in Significant Li…
LabCorp, Quest Diagnostics Both Say 2014 Revenue Was Up
By Robert Michel | From the Volume XXII No. 5 – March 30, 2015 Issue
BOTH OF THE NATION’S LARGEST clinical laboratory companies reported increased specimen volume as a result of the Accountable Care Act (ACA), as noted in their respective fourth quarter and full-year earnings reports. First to issue its earning statement was Quest Diagnostics Incorporated. On…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized